PARP10 and acute myeloid leukemia: Therefore, it is important for clinical physicians or researchers to perform rt-qPCR or high-throughput RNA sequencing to quantify the expression value of PARP10 in clinical management, based on which AML patients could be stratified into different risk group to receive comparable therapies.